<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04694287</url>
  </required_header>
  <id_info>
    <org_study_id>EBD 692</org_study_id>
    <nct_id>NCT04694287</nct_id>
  </id_info>
  <brief_title>Volume Flow Assessment to Optimize Angioplasty of Dysfunctional Dialysis Access</brief_title>
  <acronym>VOLAII</acronym>
  <official_title>Volume Flow Assessment to Optimize Angioplasty of Dysfunctional Dialysis Access. The VOLA II Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Attikon Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital of Patras</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nefrolgiki SA Hemodialysis Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Attikon Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, prospective study investigating a new concept of intra-procedural&#xD;
      percutaneous duplex ultrasound (DUS) volume flow-guided balloon angioplasty for the&#xD;
      quantification and optimization of endovascular treatment outcomes of dysfunctional&#xD;
      autologous arteriovenous fistulae (AVF).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-center, single-arm observational clinical trial investigating a&#xD;
      new functional index of success of endovascular treatment of dysfunctional AVF assessed with&#xD;
      intraprocedural percutaneous DUS. The study will include 100 consecutive patients undergoing&#xD;
      fluoroscopically-guided percutaneous balloon angioplasty due to dysfunctional AVF. Exclusion&#xD;
      criteria will be (i) patients with arteriovenous synthetic grafts. (ii) Immature AFVs not&#xD;
      previously used for hemodialysis (at least once). Patients' demographical data, dialysis&#xD;
      access history, and procedural details will be recorded. Intraprocedural volume flow&#xD;
      measurements will be obtained just prior to the procedure and after final balloon dilation,&#xD;
      before sheath removal. Clinical follow-up will be set at 6 months after the index procedure.&#xD;
      All DUS measurements will be performed using the same imaging protocol. The study's primary&#xD;
      endpoints will be (i) the quantification of angioplasty outcome using DUS volume flow&#xD;
      analysis before sheath insertion and at the end of the procedure before sheath removal and&#xD;
      (ii) to assess the correlation between volume flow at the end of the procedure and clinically&#xD;
      driven re-intervention-free rate at defined as the rate of reintervention due to dysfunction&#xD;
      recurrence of the treated AVF. Secondary endpoints will be (i) to assess the correlation&#xD;
      between volume flow and clinical success defined as high-quality dialysis for a period of at&#xD;
      least one month and (ii) identification of independent predictors of re-intervention-free&#xD;
      rate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Quantification of angioplasty outcome</measure>
    <time_frame>At the end of the procedure</time_frame>
    <description>The quantification of angioplasty outcomes will be performed using DUS volume flow analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between volume flow and clinically-driven reintervention rate</measure>
    <time_frame>6 months</time_frame>
    <description>The investigators will use ROC analysis to define cut off values of volume flow at the end of the procedure to predict clinically-driven reintervention rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Re-intervention-free rate</measure>
    <time_frame>6 months</time_frame>
    <description>The clinically driven re-intervention-free rate due to dysfunction recurrence of the treated AVF following endovascular treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of independent predictors of reintervention</measure>
    <time_frame>6 months</time_frame>
    <description>Multivariable analysis will be performed to identify independent predictors of reintervention-free rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure related complications</measure>
    <time_frame>1 week</time_frame>
    <description>Minor and major procedure related complications will be recorded</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dialysis Access Malfunction</condition>
  <arm_group>
    <arm_group_label>Volume flow group</arm_group_label>
    <description>The study will include consecutive patients undergoing standard fluoroscopically-guided percutaneous balloon angioplasty due to dysfunctional AVF. Intraprocedural volume flow measurements will be obtained just prior to the procedure and after final balloon dilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Percutaneous DUS volume flow measurements</intervention_name>
    <description>Volume flow measurements of the AFV will be obtained using intraprocedural DUS just prior to sheath insertion and at the end of the final balloon dilation, before sheath removal.</description>
    <arm_group_label>Volume flow group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients undergoing fluoroscopically-guided percutaneous balloon angioplasty&#xD;
        due to dysfunctional AVF and assessed with pre-and post-procedural volume flow measurements&#xD;
        using percutaneous DUS&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consecutive patients undergoing fluoroscopically-guided percutaneous balloon&#xD;
             angioplasty due to dysfunctional AVF&#xD;
&#xD;
          -  Signed consent form&#xD;
&#xD;
          -  Agree to the study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with arteriovenous synthetic grafts&#xD;
&#xD;
          -  Patients with contraindication to antiplatelet therapy&#xD;
&#xD;
          -  Immature AFVs, not previously used for at least one dialysis session.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Patras Universityu Hospital</name>
      <address>
        <city>Patras</city>
        <state>Achaia</state>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitris Karnabatidis, MD, PhD</last_name>
      <phone>+302613603</phone>
      <phone_ext>219</phone_ext>
      <email>karnaby@med.upatras.gr</email>
    </contact>
    <contact_backup>
      <last_name>Panagiotis Kitrou, MD, PhD</last_name>
      <phone>+302613603</phone>
      <phone_ext>218</phone_ext>
      <email>panoskitrou@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Dimitris Karnabatidis, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Panagiotis Kitrou, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kostantinos Katsanos, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>&quot;Attikon&quot; University General Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attiki</state>
        <zip>12461</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stavros Spiliopoulos, MD, PhD,</last_name>
      <phone>6937403468</phone>
      <email>stavspiliop@med.uoa.gr</email>
    </contact>
    <contact_backup>
      <last_name>Panagiotis Filippou, MD</last_name>
      <phone>+306983498386</phone>
      <email>panagiof@yahoo.gr</email>
    </contact_backup>
    <investigator>
      <last_name>Panagiotis Filippou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stavros Spiliopoulos, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kostantinos Palialexis, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nefrologiki SA Hemodialysis Centre</name>
      <address>
        <city>Athens</city>
        <state>Attiki</state>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioannis E Giannikouris, Md, MSc, PhD</last_name>
      <phone>+306946501700</phone>
      <email>igiannikouris@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 31, 2020</study_first_submitted>
  <study_first_submitted_qc>December 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>December 31, 2020</last_update_submitted>
  <last_update_submitted_qc>December 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Attikon Hospital</investigator_affiliation>
    <investigator_full_name>Stavros Spiliopoulos</investigator_full_name>
    <investigator_title>Associate Professor of Interventional Radiology</investigator_title>
  </responsible_party>
  <keyword>Percutaneous transluminal angioplasty</keyword>
  <keyword>Volume-flow measurement</keyword>
  <keyword>Autologous arteriovenous fistula</keyword>
  <keyword>Dialysis access</keyword>
  <keyword>Interventional Radiology</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Available after study publication, upon reasonable request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Starting 1 month after publication and for 2 years</ipd_time_frame>
    <ipd_access_criteria>Reasonable request (systematic review, metaanalysis)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

